Sense Diagnostics, LLC

Medtech · Private

Non-invasive radiofrequency device that detects and locates brain bleeding by measuring changes in radio signals transmitted through the skull

Claim this profile

Follows are private to you and power your alerts

Updated · senseneuro.com

Sector
Medtech
Total capital
$1.4M
Federal grants
$1.4M
2 awards · 2015–2016
Rank in peer group#316 of 477
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20152016FEDERAL ↑EQUITY ↓Cumulative $1.4M$149K$1.2M
20152016FEDERAL ↑EQUITY ↓Cumulative $1.4M$149K$1.2M

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II: Novel Device for monitoring brain hemorrhage using radio waves.$1.2M
  • Federal grantNSF · Phase I · SBIR Phase I: Novel Device for monitoring brain hemorrhage using radio waves.$149K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Daniel KincaidResearcherExecutive Officer, DirectorLinked by $149K in grants as PI
  • Carol WarnerDirectorNamed in SEC Form D filings
  • Daniel A. GeedingDirectorNamed in SEC Form D filings
  • Geoff A. KlassExecutive Officer, DirectorNamed in SEC Form D filings
  • John A. KraeutlerDirectorNamed in SEC Form D filings
  • Opeolu E. AdeoyeExecutive Officer, DirectorNamed in SEC Form D filings
Show all 11 people
  • Opeoluo AdeoyeDirectorNamed in SEC Form D filings
  • Paul GaitanExecutive OfficerNamed in SEC Form D filings
  • Roger E. EdwardsDirectorNamed in SEC Form D filings
  • Roy KulickDirectorNamed in SEC Form D filings
  • Sally A. KayDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Sense Diagnostics, Inc.Shares a founder: Daniel Kincaid, Joseph Korfhagen
  • WIDETRONIX INC.Similar federal contract value in Medtech · null in contracts
  • Beyond Air, Inc.Similar federal contract value in Medtech · null in contracts
  • Wincs International, LLCSimilar federal contract value in Medtech · null in contracts
  • CVERGENX, INC.Similar federal contract value in Medtech · null in contracts
  • PREMITEC, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .